RecruitingNCT01267591
Peripheral Artery Tonometry in Children With Type 1 Diabetes and Obese Children
Peripheral Artery Tonometry in Children With Type 1 Diabetes and Obese Children.
Sponsor
Universitaire Ziekenhuizen KU Leuven
Enrollment
70 participants
Start Date
Jan 1, 2009
Study Type
OBSERVATIONAL
Conditions
Summary
Background: The reactive hyperemia-peripheral artery tonometry (RH-PAT) is a newly developed method for noninvasive endothelial function assessment. Objective: The goal of this study is to determine whether a significant difference in RH-PAT score is present between adolescents with type 1 diabetes (T1D) in comparison with controls. We will also compare RH-PAT scores in obese adolescents versus controls.
Eligibility
Min Age: 12 YearsMax Age: 19 Years
Inclusion Criteria1
- years of age
Exclusion Criteria1
- type 2 diabetes; obesity in group of type 1 diabetes
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01267591
Related Trials
A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)
NCT0724708425 locations
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
NCT070107571 location
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
NCT05457283178 locations
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)
NCT074817471 location
Diabetes and Heart Disease Risk in Blacks
NCT000018531 location